ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAF
|
ENSG00000178573.6 | MAF |
NRL
|
ENSG00000129535.8 | NRL |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NRL | hg19_v2_chr14_-_24584138_24584223, hg19_v2_chr14_-_24553834_24553850 | 0.57 | 2.2e-02 | Click! |
MAF | hg19_v2_chr16_-_79634595_79634620 | -0.45 | 8.0e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_116700600 | 3.11 |
ENST00000227667.3 |
APOC3 |
apolipoprotein C-III |
chr11_+_116700614 | 3.10 |
ENST00000375345.1 |
APOC3 |
apolipoprotein C-III |
chr22_+_21128167 | 3.07 |
ENST00000215727.5 |
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr1_-_109935819 | 2.34 |
ENST00000538502.1 |
SORT1 |
sortilin 1 |
chr9_-_116840728 | 2.34 |
ENST00000265132.3 |
AMBP |
alpha-1-microglobulin/bikunin precursor |
chr11_-_116708302 | 2.21 |
ENST00000375320.1 ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
APOA1 |
apolipoprotein A-I |
chr4_+_100495864 | 2.18 |
ENST00000265517.5 ENST00000422897.2 |
MTTP |
microsomal triglyceride transfer protein |
chr11_+_22688150 | 1.74 |
ENST00000454584.2 |
GAS2 |
growth arrest-specific 2 |
chr11_-_2160180 | 1.63 |
ENST00000381406.4 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr2_-_188419078 | 1.57 |
ENST00000437725.1 ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr18_+_29171689 | 1.47 |
ENST00000237014.3 |
TTR |
transthyretin |
chr4_+_128554081 | 1.30 |
ENST00000335251.6 ENST00000296461.5 |
INTU |
inturned planar cell polarity protein |
chr3_-_50340996 | 1.23 |
ENST00000266031.4 ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1 |
hyaluronoglucosaminidase 1 |
chr3_+_186330712 | 1.14 |
ENST00000411641.2 ENST00000273784.5 |
AHSG |
alpha-2-HS-glycoprotein |
chr8_+_56014949 | 1.12 |
ENST00000327381.6 |
XKR4 |
XK, Kell blood group complex subunit-related family, member 4 |
chr19_+_45418067 | 1.11 |
ENST00000589078.1 ENST00000586638.1 |
APOC1 |
apolipoprotein C-I |
chr3_+_52828805 | 1.09 |
ENST00000416872.2 ENST00000449956.2 |
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
chr11_-_2160611 | 1.07 |
ENST00000416167.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr19_+_45417504 | 1.06 |
ENST00000588750.1 ENST00000588802.1 |
APOC1 |
apolipoprotein C-I |
chr3_+_53880588 | 1.05 |
ENST00000288167.3 ENST00000494338.1 |
IL17RB |
interleukin 17 receptor B |
chr3_-_194991876 | 1.04 |
ENST00000310380.6 |
XXYLT1 |
xyloside xylosyltransferase 1 |
chr6_+_31895254 | 1.04 |
ENST00000299367.5 ENST00000442278.2 |
C2 |
complement component 2 |
chr2_-_220083076 | 1.03 |
ENST00000295750.4 |
ABCB6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr6_+_31895467 | 1.00 |
ENST00000556679.1 ENST00000456570.1 |
CFB CFB |
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr2_+_11674213 | 0.97 |
ENST00000381486.2 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr19_+_45417921 | 0.97 |
ENST00000252491.4 ENST00000592885.1 ENST00000589781.1 |
APOC1 |
apolipoprotein C-I |
chr19_+_45417812 | 0.95 |
ENST00000592535.1 |
APOC1 |
apolipoprotein C-I |
chr17_+_1674982 | 0.95 |
ENST00000572048.1 ENST00000573763.1 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr20_+_34802295 | 0.94 |
ENST00000432603.1 |
EPB41L1 |
erythrocyte membrane protein band 4.1-like 1 |
chr17_+_41052808 | 0.93 |
ENST00000592383.1 ENST00000253801.2 ENST00000585489.1 |
G6PC |
glucose-6-phosphatase, catalytic subunit |
chr18_-_25616519 | 0.93 |
ENST00000399380.3 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
chr2_+_128180842 | 0.93 |
ENST00000402125.2 |
PROC |
protein C (inactivator of coagulation factors Va and VIIIa) |
chr2_-_188419200 | 0.92 |
ENST00000233156.3 ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr1_-_57431679 | 0.91 |
ENST00000371237.4 ENST00000535057.1 ENST00000543257.1 |
C8B |
complement component 8, beta polypeptide |
chr2_+_138722028 | 0.91 |
ENST00000280096.5 |
HNMT |
histamine N-methyltransferase |
chr6_+_31895480 | 0.89 |
ENST00000418949.2 ENST00000383177.3 ENST00000477310.1 |
C2 CFB |
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr20_+_34203794 | 0.89 |
ENST00000374273.3 |
SPAG4 |
sperm associated antigen 4 |
chr17_+_41003166 | 0.88 |
ENST00000308423.2 |
AOC3 |
amine oxidase, copper containing 3 |
chr18_+_55862622 | 0.88 |
ENST00000456173.2 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr1_-_110306562 | 0.85 |
ENST00000369805.3 |
EPS8L3 |
EPS8-like 3 |
chr7_+_26331541 | 0.82 |
ENST00000416246.1 ENST00000338523.4 ENST00000412416.1 |
SNX10 |
sorting nexin 10 |
chr13_-_111214015 | 0.79 |
ENST00000267328.3 |
RAB20 |
RAB20, member RAS oncogene family |
chr4_+_140586922 | 0.78 |
ENST00000265498.1 ENST00000506797.1 |
MGST2 |
microsomal glutathione S-transferase 2 |
chr20_+_45338126 | 0.76 |
ENST00000359271.2 |
SLC2A10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
chr7_-_22234381 | 0.74 |
ENST00000458533.1 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
chr20_-_22565101 | 0.72 |
ENST00000419308.2 |
FOXA2 |
forkhead box A2 |
chr1_-_110306526 | 0.72 |
ENST00000361965.4 ENST00000361852.4 |
EPS8L3 |
EPS8-like 3 |
chr1_+_2004901 | 0.72 |
ENST00000400921.2 |
PRKCZ |
protein kinase C, zeta |
chr17_+_1665345 | 0.70 |
ENST00000576406.1 ENST00000571149.1 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr2_-_220435963 | 0.70 |
ENST00000373876.1 ENST00000404537.1 ENST00000603926.1 ENST00000373873.4 ENST00000289656.3 |
OBSL1 |
obscurin-like 1 |
chr17_-_56494713 | 0.69 |
ENST00000407977.2 |
RNF43 |
ring finger protein 43 |
chr17_-_56494908 | 0.69 |
ENST00000577716.1 |
RNF43 |
ring finger protein 43 |
chr17_-_56494882 | 0.68 |
ENST00000584437.1 |
RNF43 |
ring finger protein 43 |
chr12_+_71833550 | 0.67 |
ENST00000266674.5 |
LGR5 |
leucine-rich repeat containing G protein-coupled receptor 5 |
chr11_+_61520075 | 0.63 |
ENST00000278836.5 |
MYRF |
myelin regulatory factor |
chr9_-_140351928 | 0.63 |
ENST00000339554.3 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chr19_-_10450287 | 0.63 |
ENST00000589261.1 ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr21_+_44589118 | 0.62 |
ENST00000291554.2 |
CRYAA |
crystallin, alpha A |
chr11_+_101785727 | 0.58 |
ENST00000263468.8 |
KIAA1377 |
KIAA1377 |
chr3_+_124303472 | 0.58 |
ENST00000291478.5 |
KALRN |
kalirin, RhoGEF kinase |
chr8_+_123793633 | 0.57 |
ENST00000314393.4 |
ZHX2 |
zinc fingers and homeoboxes 2 |
chr20_-_48530230 | 0.56 |
ENST00000422556.1 |
SPATA2 |
spermatogenesis associated 2 |
chr12_+_51318513 | 0.56 |
ENST00000332160.4 |
METTL7A |
methyltransferase like 7A |
chr12_-_71182695 | 0.54 |
ENST00000342084.4 |
PTPRR |
protein tyrosine phosphatase, receptor type, R |
chr20_+_30697510 | 0.54 |
ENST00000217315.5 |
TM9SF4 |
transmembrane 9 superfamily protein member 4 |
chrX_+_105969893 | 0.53 |
ENST00000255499.2 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr9_-_75567962 | 0.53 |
ENST00000297785.3 ENST00000376939.1 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
chr7_-_51384451 | 0.53 |
ENST00000441453.1 ENST00000265136.7 ENST00000395542.2 ENST00000395540.2 |
COBL |
cordon-bleu WH2 repeat protein |
chr15_-_52587945 | 0.51 |
ENST00000443683.2 ENST00000558479.1 ENST00000261839.7 |
MYO5C |
myosin VC |
chr20_+_30697298 | 0.50 |
ENST00000398022.2 |
TM9SF4 |
transmembrane 9 superfamily protein member 4 |
chr1_+_2005425 | 0.50 |
ENST00000461106.2 |
PRKCZ |
protein kinase C, zeta |
chr16_-_18468926 | 0.48 |
ENST00000545114.1 |
RP11-1212A22.4 |
LOC339047 protein; Nuclear pore complex-interacting protein family member A3; Nuclear pore complex-interacting protein family member A5; Protein PKD1P1 |
chr1_+_28764653 | 0.48 |
ENST00000373836.3 |
PHACTR4 |
phosphatase and actin regulator 4 |
chr2_+_234296792 | 0.47 |
ENST00000409813.3 |
DGKD |
diacylglycerol kinase, delta 130kDa |
chrX_+_51928002 | 0.47 |
ENST00000375626.3 |
MAGED4 |
melanoma antigen family D, 4 |
chr6_-_111136513 | 0.46 |
ENST00000368911.3 |
CDK19 |
cyclin-dependent kinase 19 |
chr2_+_231902193 | 0.46 |
ENST00000373640.4 |
C2orf72 |
chromosome 2 open reading frame 72 |
chr6_+_32936353 | 0.46 |
ENST00000374825.4 |
BRD2 |
bromodomain containing 2 |
chr10_-_11653753 | 0.45 |
ENST00000609104.1 |
USP6NL |
USP6 N-terminal like |
chr9_-_99145957 | 0.45 |
ENST00000375257.1 ENST00000253270.7 ENST00000375259.4 |
SLC35D2 |
solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 |
chr19_-_10450328 | 0.45 |
ENST00000160262.5 |
ICAM3 |
intercellular adhesion molecule 3 |
chr7_-_100239132 | 0.44 |
ENST00000223051.3 ENST00000431692.1 |
TFR2 |
transferrin receptor 2 |
chr10_+_31610064 | 0.42 |
ENST00000446923.2 ENST00000559476.1 |
ZEB1 |
zinc finger E-box binding homeobox 1 |
chr17_-_28618948 | 0.41 |
ENST00000261714.6 |
BLMH |
bleomycin hydrolase |
chr2_-_136678123 | 0.41 |
ENST00000422708.1 |
DARS |
aspartyl-tRNA synthetase |
chr1_+_6105974 | 0.41 |
ENST00000378083.3 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr2_-_27357479 | 0.40 |
ENST00000406567.3 ENST00000260643.2 |
PREB |
prolactin regulatory element binding |
chr6_-_25930819 | 0.40 |
ENST00000360488.3 |
SLC17A2 |
solute carrier family 17, member 2 |
chr20_-_45985464 | 0.40 |
ENST00000458360.2 ENST00000262975.4 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
chr7_-_71877318 | 0.39 |
ENST00000395275.2 |
CALN1 |
calneuron 1 |
chr11_+_125365110 | 0.39 |
ENST00000527818.1 |
AP000708.1 |
AP000708.1 |
chr11_+_101983176 | 0.39 |
ENST00000524575.1 |
YAP1 |
Yes-associated protein 1 |
chr2_+_71357434 | 0.39 |
ENST00000244230.2 |
MPHOSPH10 |
M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) |
chr1_-_161279749 | 0.39 |
ENST00000533357.1 ENST00000360451.6 ENST00000336559.4 |
MPZ |
myelin protein zero |
chr5_+_179125368 | 0.39 |
ENST00000502296.1 ENST00000504734.1 ENST00000415618.2 |
CANX |
calnexin |
chr2_-_220173685 | 0.39 |
ENST00000423636.2 ENST00000442029.1 ENST00000412847.1 |
PTPRN |
protein tyrosine phosphatase, receptor type, N |
chr2_+_118846008 | 0.39 |
ENST00000245787.4 |
INSIG2 |
insulin induced gene 2 |
chr6_+_32407619 | 0.39 |
ENST00000395388.2 ENST00000374982.5 |
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
chr12_+_118573663 | 0.38 |
ENST00000261313.2 |
PEBP1 |
phosphatidylethanolamine binding protein 1 |
chr15_+_59903975 | 0.38 |
ENST00000560585.1 ENST00000396065.1 |
GCNT3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
chr9_-_112260531 | 0.38 |
ENST00000374541.2 ENST00000262539.3 |
PTPN3 |
protein tyrosine phosphatase, non-receptor type 3 |
chr17_+_40714092 | 0.37 |
ENST00000420359.1 ENST00000449624.1 ENST00000585811.1 ENST00000585909.1 ENST00000586771.1 ENST00000421097.2 ENST00000591779.1 ENST00000587858.1 ENST00000587214.1 ENST00000587157.1 ENST00000590958.1 ENST00000393818.2 |
COASY |
CoA synthase |
chr11_+_64808675 | 0.37 |
ENST00000529996.1 |
SAC3D1 |
SAC3 domain containing 1 |
chr10_+_21823079 | 0.36 |
ENST00000377100.3 ENST00000377072.3 ENST00000446906.2 |
MLLT10 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr20_+_47835884 | 0.36 |
ENST00000371764.4 |
DDX27 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 |
chr1_-_39407450 | 0.36 |
ENST00000372990.1 |
RHBDL2 |
rhomboid, veinlet-like 2 (Drosophila) |
chr17_+_55183261 | 0.36 |
ENST00000576295.1 |
AKAP1 |
A kinase (PRKA) anchor protein 1 |
chr17_+_635652 | 0.36 |
ENST00000308278.8 |
FAM57A |
family with sequence similarity 57, member A |
chr6_-_25930904 | 0.35 |
ENST00000377850.3 |
SLC17A2 |
solute carrier family 17, member 2 |
chr10_+_57358750 | 0.35 |
ENST00000512524.2 |
MTRNR2L5 |
MT-RNR2-like 5 |
chr3_+_193853927 | 0.35 |
ENST00000232424.3 |
HES1 |
hes family bHLH transcription factor 1 |
chr17_+_635786 | 0.35 |
ENST00000572018.1 ENST00000301324.8 |
FAM57A |
family with sequence similarity 57, member A |
chr17_-_73389737 | 0.35 |
ENST00000392563.1 |
GRB2 |
growth factor receptor-bound protein 2 |
chr2_-_74757066 | 0.35 |
ENST00000377526.3 |
AUP1 |
ancient ubiquitous protein 1 |
chr6_+_37321823 | 0.35 |
ENST00000487950.1 ENST00000469731.1 |
RNF8 |
ring finger protein 8, E3 ubiquitin protein ligase |
chr3_+_184098065 | 0.34 |
ENST00000348986.3 |
CHRD |
chordin |
chr17_+_76311791 | 0.34 |
ENST00000586321.1 |
AC061992.2 |
AC061992.2 |
chrX_+_48681768 | 0.34 |
ENST00000430858.1 |
HDAC6 |
histone deacetylase 6 |
chr3_-_53880401 | 0.34 |
ENST00000315251.6 |
CHDH |
choline dehydrogenase |
chr6_+_31582961 | 0.33 |
ENST00000376059.3 ENST00000337917.7 |
AIF1 |
allograft inflammatory factor 1 |
chr17_+_55173933 | 0.33 |
ENST00000539273.1 |
AKAP1 |
A kinase (PRKA) anchor protein 1 |
chr14_-_106237742 | 0.33 |
ENST00000390551.2 |
IGHG3 |
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr3_+_12392971 | 0.33 |
ENST00000287820.6 |
PPARG |
peroxisome proliferator-activated receptor gamma |
chr17_-_74163159 | 0.32 |
ENST00000591615.1 |
RNF157 |
ring finger protein 157 |
chrX_+_17755563 | 0.32 |
ENST00000380045.3 ENST00000380041.3 ENST00000380043.3 ENST00000398080.1 |
SCML1 |
sex comb on midleg-like 1 (Drosophila) |
chr7_+_100136811 | 0.32 |
ENST00000300176.4 ENST00000262935.4 |
AGFG2 |
ArfGAP with FG repeats 2 |
chr6_-_133035185 | 0.32 |
ENST00000367928.4 |
VNN1 |
vanin 1 |
chr10_-_62704005 | 0.32 |
ENST00000337910.5 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr11_+_89867803 | 0.31 |
ENST00000321955.4 ENST00000525171.1 ENST00000375944.3 |
NAALAD2 |
N-acetylated alpha-linked acidic dipeptidase 2 |
chr12_+_112204691 | 0.31 |
ENST00000416293.3 ENST00000261733.2 |
ALDH2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
chr10_+_21823243 | 0.31 |
ENST00000307729.7 ENST00000377091.2 |
MLLT10 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr17_-_76128488 | 0.31 |
ENST00000322914.3 |
TMC6 |
transmembrane channel-like 6 |
chr22_+_22712087 | 0.30 |
ENST00000390294.2 |
IGLV1-47 |
immunoglobulin lambda variable 1-47 |
chr15_+_89346699 | 0.30 |
ENST00000558207.1 |
ACAN |
aggrecan |
chr1_-_160492994 | 0.30 |
ENST00000368055.1 ENST00000368057.3 ENST00000368059.3 |
SLAMF6 |
SLAM family member 6 |
chrX_-_118827333 | 0.29 |
ENST00000360156.7 ENST00000354228.4 ENST00000489216.1 ENST00000354416.3 ENST00000394610.1 ENST00000343984.5 |
SEPT6 |
septin 6 |
chr3_-_9811595 | 0.29 |
ENST00000256460.3 |
CAMK1 |
calcium/calmodulin-dependent protein kinase I |
chr14_-_23479331 | 0.29 |
ENST00000397377.1 ENST00000397379.3 ENST00000406429.2 ENST00000341470.4 ENST00000555998.1 ENST00000397376.2 ENST00000553675.1 ENST00000553931.1 ENST00000555575.1 ENST00000553958.1 ENST00000555098.1 ENST00000556419.1 ENST00000553606.1 ENST00000299088.6 ENST00000554179.1 ENST00000397382.4 |
C14orf93 |
chromosome 14 open reading frame 93 |
chr5_+_175298674 | 0.29 |
ENST00000514150.1 |
CPLX2 |
complexin 2 |
chr6_+_33168597 | 0.29 |
ENST00000374675.3 |
SLC39A7 |
solute carrier family 39 (zinc transporter), member 7 |
chr5_+_180682720 | 0.29 |
ENST00000599439.1 |
AC008443.1 |
CDNA: FLJ23158 fis, clone LNG09623; Uncharacterized protein |
chr17_+_16318909 | 0.28 |
ENST00000577397.1 |
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
chr5_+_175298573 | 0.28 |
ENST00000512824.1 |
CPLX2 |
complexin 2 |
chr3_+_184097836 | 0.28 |
ENST00000204604.1 ENST00000310236.3 |
CHRD |
chordin |
chr6_+_33168637 | 0.28 |
ENST00000374677.3 |
SLC39A7 |
solute carrier family 39 (zinc transporter), member 7 |
chr2_+_71127699 | 0.28 |
ENST00000234392.2 |
VAX2 |
ventral anterior homeobox 2 |
chr1_-_247094628 | 0.27 |
ENST00000366508.1 ENST00000326225.3 ENST00000391829.2 |
AHCTF1 |
AT hook containing transcription factor 1 |
chr15_+_41851211 | 0.27 |
ENST00000263798.3 |
TYRO3 |
TYRO3 protein tyrosine kinase |
chr12_+_7282795 | 0.27 |
ENST00000266546.6 |
CLSTN3 |
calsyntenin 3 |
chr16_+_12059091 | 0.27 |
ENST00000562385.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr2_-_64371546 | 0.27 |
ENST00000358912.4 |
PELI1 |
pellino E3 ubiquitin protein ligase 1 |
chr3_+_184097905 | 0.27 |
ENST00000450923.1 |
CHRD |
chordin |
chr2_+_74757050 | 0.26 |
ENST00000352222.3 ENST00000437202.1 |
HTRA2 |
HtrA serine peptidase 2 |
chr17_+_16318850 | 0.26 |
ENST00000338560.7 |
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
chr12_-_81763127 | 0.26 |
ENST00000541017.1 |
PPFIA2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr9_-_98279241 | 0.26 |
ENST00000437951.1 ENST00000375274.2 ENST00000430669.2 ENST00000468211.2 |
PTCH1 |
patched 1 |
chr13_+_28195988 | 0.25 |
ENST00000399697.3 ENST00000399696.1 |
POLR1D |
polymerase (RNA) I polypeptide D, 16kDa |
chr1_+_212738676 | 0.25 |
ENST00000366981.4 ENST00000366987.2 |
ATF3 |
activating transcription factor 3 |
chr10_-_50970322 | 0.25 |
ENST00000374103.4 |
OGDHL |
oxoglutarate dehydrogenase-like |
chr11_+_34938119 | 0.25 |
ENST00000227868.4 ENST00000430469.2 ENST00000533262.1 |
PDHX |
pyruvate dehydrogenase complex, component X |
chr1_-_25256368 | 0.25 |
ENST00000308873.6 |
RUNX3 |
runt-related transcription factor 3 |
chr20_-_48782639 | 0.25 |
ENST00000435301.2 |
RP11-112L6.3 |
RP11-112L6.3 |
chr2_+_86333301 | 0.24 |
ENST00000254630.7 |
PTCD3 |
pentatricopeptide repeat domain 3 |
chr21_-_45671014 | 0.24 |
ENST00000436357.1 |
DNMT3L |
DNA (cytosine-5-)-methyltransferase 3-like |
chr20_-_60942361 | 0.24 |
ENST00000252999.3 |
LAMA5 |
laminin, alpha 5 |
chr6_-_131949200 | 0.24 |
ENST00000539158.1 ENST00000368058.1 |
MED23 |
mediator complex subunit 23 |
chr12_-_719573 | 0.24 |
ENST00000397265.3 |
NINJ2 |
ninjurin 2 |
chr17_-_73389854 | 0.24 |
ENST00000578961.1 ENST00000392564.1 ENST00000582582.1 |
GRB2 |
growth factor receptor-bound protein 2 |
chr16_+_2510081 | 0.24 |
ENST00000361837.4 ENST00000569496.1 ENST00000567489.1 ENST00000563531.1 ENST00000483320.1 |
C16orf59 |
chromosome 16 open reading frame 59 |
chr1_-_1293904 | 0.24 |
ENST00000309212.6 ENST00000342753.4 ENST00000445648.2 |
MXRA8 |
matrix-remodelling associated 8 |
chr3_-_138553779 | 0.24 |
ENST00000461451.1 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
chr16_-_15474904 | 0.24 |
ENST00000534094.1 |
NPIPA5 |
nuclear pore complex interacting protein family, member A5 |
chr22_+_31031639 | 0.24 |
ENST00000343605.4 ENST00000300385.8 |
SLC35E4 |
solute carrier family 35, member E4 |
chr2_-_219134822 | 0.23 |
ENST00000444053.1 ENST00000248450.4 |
AAMP |
angio-associated, migratory cell protein |
chr11_+_89867681 | 0.23 |
ENST00000534061.1 |
NAALAD2 |
N-acetylated alpha-linked acidic dipeptidase 2 |
chr7_-_99679324 | 0.23 |
ENST00000292393.5 ENST00000413658.2 ENST00000412947.1 ENST00000441298.1 ENST00000449785.1 ENST00000299667.4 ENST00000424697.1 |
ZNF3 |
zinc finger protein 3 |
chrX_-_21776281 | 0.23 |
ENST00000379494.3 |
SMPX |
small muscle protein, X-linked |
chr3_-_138553594 | 0.23 |
ENST00000477593.1 ENST00000483968.1 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
chr19_+_11485333 | 0.23 |
ENST00000312423.2 |
SWSAP1 |
SWIM-type zinc finger 7 associated protein 1 |
chr16_+_83986827 | 0.23 |
ENST00000393306.1 ENST00000565123.1 |
OSGIN1 |
oxidative stress induced growth inhibitor 1 |
chr5_+_149877334 | 0.23 |
ENST00000523767.1 |
NDST1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr2_+_169312725 | 0.22 |
ENST00000392687.4 |
CERS6 |
ceramide synthase 6 |
chr6_+_22146851 | 0.22 |
ENST00000606197.1 |
CASC15 |
cancer susceptibility candidate 15 (non-protein coding) |
chr8_+_17780483 | 0.22 |
ENST00000517730.1 ENST00000518537.1 ENST00000523055.1 ENST00000519253.1 |
PCM1 |
pericentriolar material 1 |
chr3_+_185080908 | 0.22 |
ENST00000265026.3 |
MAP3K13 |
mitogen-activated protein kinase kinase kinase 13 |
chr16_+_20912382 | 0.22 |
ENST00000396052.2 |
LYRM1 |
LYR motif containing 1 |
chr16_+_71929397 | 0.22 |
ENST00000537613.1 ENST00000424485.2 ENST00000606369.1 ENST00000329908.8 ENST00000538850.1 ENST00000541918.1 ENST00000534994.1 ENST00000378798.5 ENST00000539186.1 |
IST1 |
increased sodium tolerance 1 homolog (yeast) |
chr5_-_111091948 | 0.22 |
ENST00000447165.2 |
NREP |
neuronal regeneration related protein |
chr4_+_39460689 | 0.22 |
ENST00000381846.1 |
LIAS |
lipoic acid synthetase |
chrX_+_128913906 | 0.22 |
ENST00000356892.3 |
SASH3 |
SAM and SH3 domain containing 3 |
chr4_-_185395672 | 0.21 |
ENST00000393593.3 |
IRF2 |
interferon regulatory factor 2 |
chr17_-_10325261 | 0.21 |
ENST00000403437.2 |
MYH8 |
myosin, heavy chain 8, skeletal muscle, perinatal |
chr9_-_86571628 | 0.21 |
ENST00000376344.3 |
C9orf64 |
chromosome 9 open reading frame 64 |
chr1_-_169680745 | 0.21 |
ENST00000236147.4 |
SELL |
selectin L |
chr4_+_39460659 | 0.21 |
ENST00000513731.1 |
LIAS |
lipoic acid synthetase |
chr11_-_66103932 | 0.21 |
ENST00000311320.4 |
RIN1 |
Ras and Rab interactor 1 |
chr14_-_106092403 | 0.21 |
ENST00000390543.2 |
IGHG4 |
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr1_-_1297157 | 0.21 |
ENST00000477278.2 |
MXRA8 |
matrix-remodelling associated 8 |
chr2_-_219134343 | 0.21 |
ENST00000447885.1 ENST00000420660.1 |
AAMP |
angio-associated, migratory cell protein |
chr6_+_158733692 | 0.21 |
ENST00000367094.2 ENST00000367097.3 |
TULP4 |
tubby like protein 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 10.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 3.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 1.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 8.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 4.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 2.3 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 2.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.4 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.1 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 1.0 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.3 | 0.8 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.4 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 2.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 0.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 3.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 7.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 2.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 1.8 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.0 | 0.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.0 | 0.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.9 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.0 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 8.4 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
1.0 | 4.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.6 | 2.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 2.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.4 | 3.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 1.2 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 2.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 0.9 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.3 | 2.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 0.9 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.3 | 2.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.2 | 0.7 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 2.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.2 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.5 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.5 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 | 0.5 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.1 | 2.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 1.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 2.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.5 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.4 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 1.0 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 1.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.3 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 1.3 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.1 | 0.3 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.5 | GO:0071672 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.1 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 0.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 1.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 1.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.5 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.3 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.1 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:1903939 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.2 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.1 | 0.2 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.1 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:0042426 | choline catabolic process(GO:0042426) |
0.0 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 1.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.0 | 0.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.0 | 0.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.0 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.1 | GO:1901297 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.3 | GO:0033089 | pantothenate metabolic process(GO:0015939) positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
0.0 | 0.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) response to water-immersion restraint stress(GO:1990785) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.7 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.3 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 1.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.0 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
0.0 | 0.1 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.0 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.0 | 0.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0060021 | palate development(GO:0060021) |
0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
0.0 | 0.6 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.4 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.0 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.0 | 0.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.0 | 0.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.0 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.4 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.0 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.0 | 0.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0007568 | aging(GO:0007568) |
0.0 | 0.3 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.0 | GO:0045726 | regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0016485 | protein processing(GO:0016485) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 8.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 4.1 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 2.9 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 0.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.6 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 1.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.9 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.2 | GO:0043260 | laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
0.1 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 1.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0044297 | cell body(GO:0044297) |
0.0 | 5.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.3 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 1.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 2.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 1.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 1.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 2.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 3.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 2.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 2.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 7.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |